Comorbidities in Chronic Kidney Disease (CKD) |
Autore | Jankowski Joachim |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (184 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
arterial stiffness
carotid–femoral pulse wave velocity hemodialysis p-cresyl sulfate uremic toxins arterial calcification lipid metabolism inflammation coagulation endothelial dysfunction epigenetics chronic kidney disease uremic cardiopathy left ventricular hypertrophy phosphate PTH FGF23 klotho sclerostin chronodisruption chronodisruptor circadian rhythm internal clock uremia uremic cardiomyopathy organ crosstalk cardiorenal syndrome left-ventricular hypertrophy heart failure cardiac fibrosis cardiovascular disease vascular calcification experimental rodent models FGFG23 Klotho Wnt/β-catenin CKD parathyroid hormone secondary hyperparathyroidism uremic toxin ageing end-stage kidney disease premature ageing senescence bone gut cardiovascular CKD–MBD comorbidity fibrosis calcification |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Comorbidities in Chronic Kidney Disease |
Record Nr. | UNINA-9910557705903321 |
Jankowski Joachim
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches |
Autore | Jeon Byeong Hwa |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (368 p.) |
Soggetto topico |
Technology: general issues
Biotechnology |
Soggetto non controllato |
endothelial cells
oxidative stress inflammageing endothelial dysfunction aldehyde dehydrogenase-2 cardiovascular disease neurovascular disease vascular inflammation APE1/Ref-1 cardiovascular diseases subcellular localization serological biomarkers atherosclerosis aerobic exercise PCSK9 LOX-1 insulin resistance macrophage polarity serum γ-glutamyltransferase essential hypertension cardiovascular risk factors angiogenesis nargenicin A1 compound 9 VEGF VEGFR2 HIF-1α electronegative low-density lipoprotein LDL(-) L5 LDL oxidized LDL oxLDL ADMA arginine arginine paradox BH4 blood pressure COVID-19 dietary supplements endothelium eNOS uncoupling heart failure hypertension L-arginine myocardial infarction NADPH nitric oxide peripheral artery disease ApoE knockout mouse atorvastatin VCAM-1 galectin-3 neutrophil/lymphocyte ratio electronegative LDL LDL(−) lectin-like oxLDL receptor-1 dyslipidemia chronic venous insufficiency prolyl oligopeptidase (POP) inflammation endothelial disfunction lung disease endothelial to mesenchymal transition pulmonary hypertension pulmonary fibrosis metformin diabetes CV risk hyperglycemia glycated lipoproteins glycated LDL glycated HDL endothelial cell dysfunction molecular mechanisms epigenetic factors therapeutic approaches vasoactive factors EndoMT TGF-β epigenetics endothelial cell glycolysis metabolism pathological angiogenesis tumor microenvironment MRI (magnetic resonance imaging) high-fat diets plaque burden low-level laser therapy phototherapy vascular disease healing ischemia vascular calcification chronic kidney disease CKD uremic toxins hyperphosphatemia vascular smooth muscle cells VSMCs macrophages |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Endothelial Dysfunction |
Record Nr. | UNINA-9910566471803321 |
Jeon Byeong Hwa
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|